Bio-Reference Laboratories, Inc. Named to the 2004 Forbes List of the 200 Best Small Companies.ELMWOOD PARK Elmwood Park, village (1990 pop. 23,206), Cook co., NE Ill., a suburb of Chicago; inc. 1914. It is chiefly residential. , N.J. -- Company Ranked # 26 on Annual List Based on Consistent Pattern of Growth over the Past Five Years as Well as the Last Twelve Months Bio-Reference Laboratories, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :BRLI BRLI Bio Rad Laboratories Inc ) announced today that Forbes Magazine has ranked BRLI #26 in its 2004 annual list of the top 200 Best Small Companies, released in the October 2004 issue of the Forbes magazine. This is the first year that Bio-Reference Laboratories, Inc. has appeared on the list. The magazine selected its candidates based on their pattern of positive growth during a five-year period as well as the last 12 months. They selected qualifying companies based on their sales in a $5 million to $750 million range along with net profit margins greater than 5% and share prices above $5 as of October 1 of this year. This is the third national publication to rank BRLI near the top of its list of outstanding small companies. Earlier this year, BRLI was ranked #6 in the 2004 Fortune Small Business list of 100 of America's Fastest-Growing Small Public Companies and #16 in the 2004 BusinessWeek list of the 100 Best Small Companies. About Bio-Reference Laboratories, Inc. The Company is the largest independent regional clinical laboratory in the Northeast and has major market positions in physician offices, nursing homes and correctional institutions. The Company is a full service clinical laboratory with specialty capability, especially in the areas of genomics, oncology, correctional health, and complimentary medicine. PSIMedica, a business unit of the Company, is a clinical knowledge management (CKM CKM Cabibbo-Kobayashi-Maskawa (quark mixing matrix) CKM Certified Knowledge Manager (trademark of Hudson Associates Consulting, Inc. ) organization offering an array of information solutions for reducing healthcare costs and improving quality performance that are based on a flexible, scalable software analytical engine A programmable calculator designed by British scientist Charles Babbage. After his Difference Engine failed its test in 1833, Babbage started the design of the Analytical Engine in 1834. that utilizes all available source information, including claims data, enrollment data, prescription data and laboratory data. The Company provides a comprehensive connectivity solution to physicians, which includes disease management, laboratory reporting and ordering, as well as claims and eligibility processing through CareEvolve, its web-based healthcare portal. Statements included in this release that are not historical in nature, are intended to be, and are hereby identified as "forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. ". Statements looking forward in time are included in this release pursuant to the "safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such statements involve known and unknown risks and uncertainties that may cause the Company's actual results in future periods to be materially different from any future performance suggested herein. www.bioreference.com |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion